| Active ingredient (INN) | Nepafenac |
|---|---|
| Brand names |
|---|
| Nevanac |
| Therapeutic category | Auto-created by Agenzia Italiana del Farmaco — Carenze scraper |
|---|
| Controlled substance | No |
|---|
| Marketing-authorisation holders | Novartis Pharmaceuticals Australia Pty Ltd |
|---|
| Registrations on file | 2 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| ILEVRO nepafenac 0.3% eye drops, suspension, bottle | 0.3% | — | 🇦🇺 AU | Novartis Pharmaceuticals Australia Pty Ltd | Active |
| ILEVRO nepafenac 0.3% eye drops, suspension, oval bottle | 0.3% | — | 🇦🇺 AU | Novartis Pharmaceuticals Australia Pty Ltd | Active |